Lee Sung 4
4 · Vir Biotechnology, Inc. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Lee Sung
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-22+40,000→ 106,500 total - Award
Stock Option (Right to Buy)
2024-02-22+80,000→ 80,000 totalExercise: $10.11Exp: 2034-02-21→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter.